The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Lorlatinib in advanced ALK-positive NSCLC after prior progression on ALK inhibitors: real-world experience in Russia”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2026 |
D. T. Marinov, D. V. Perunov, L. N. Nefedova, I. S. Polyakov, A. F. Nasretdinov, A. A. Izmailov, A. V. Sultanbaev, M. I. Andrievskikh, R. A. Zukov, I. L. Obraz, E. G. Ovchinnikova, V. A. Grishin, A. I. Nikiforov, E. I. Rossokha, A. S. Galanov, V. V. Petkau, A. V. Mishina, D. M. Ponomarenko, D. Yu. Yukalchuk, T. A. Sannikova, Yu. V. Trefilova, E. V. Peganova, V. V. Kozlov, A. V. Sobolev, N. P. Modin, A. E. Gorokhov, K. K. Laktionov. Efficacy of alectinib in advanced ALK-positive non-small cell lung cancer: Results from the Russian multicenter KARL-005 study, Meditsinskiy sovet = Medical Council. 1;1. https://doi.org/10.21518/ms2026-255 |